AbTis is a pioneering biotechnology company leveraging its proprietary AbClick® platform technology to revolutionize antibody conjugate therapies. AbTis’ innovative technologies enable site-selective conjugation of diverse therapeutic payloads to antibodies through a streamlined, cost-efficient process.